Impact of race and gender on antithrombotic therapy.

  title={Impact of race and gender on antithrombotic therapy.},
  author={Davide Capodanno and Dominick Joseph Angiolillo},
  journal={Thrombosis and haemostasis},
  volume={104 3},
Large randomised trials support the use of a variety of antithrombotic drugs for treatment of atherothrombotic disease processes leading to cardiovascular disease. The heterogeneous case-mix of patients enrolled in these trials, however, hamper the attempt to generalise their findings to subgroups which are not sufficiently represented in the study population, such as women and ethnic minorities. Sex- and race-specific disparities in the clinical presentation, management, and outcomes of… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 22 extracted citations

Women and the management of acute coronary syndrome.

Canadian journal of physiology and pharmacology • 2012
View 5 Excerpts
Highly Influenced

Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology • 2017
View 1 Excerpt

Gender Differences in Cardiovascular Drugs

Cardiovascular Drugs and Therapy • 2015
View 2 Excerpts

Similar Papers

Loading similar papers…